Diagnostics stocks
Daily analysis · Oct 27, 2026
CareDx, Inc. (CDNA) had the widest one-year change at +376.2%, while Lucid Diagnostics Inc. (LUCD) had the largest one-day move at +21.8%.
- Guardant Health, Inc. (GH): +2.5% one day move, large cap
- Diagnósticos da América S.A. (DASA3.SA): −43.2% one day move, mid cap
- GeneDx Holdings Corp. (WGS): +9.1% one day move, small cap
Generated from today's data · Not investment advice
Heavily traded in Diagnostics
Turnover over $10M/day35 of about 130 companies in this theme turn over more than $10M in a typical session. Largest market value first. Data as of Oct 27, 2026.
| Company | Turnover | 1Y return | Next report |
|---|---|---|---|
| NTRANatera, Inc. | $559.11M | +110.64% | Reports Nov 5, 2026 |
| DGXQuest Diagnostics Incorporated | $227.07M | +35.98% | — |
| LHLabcorp Holdings Inc. | $207.77M | +20.30% | Reports Oct 28, 2026 |
| GHGuardant Health, Inc. | $302.81M | +144.53% | Reports Nov 5, 2026 |
| TEMTempus AI, Inc. | $421.82M | −26.67% | Reports Nov 2, 2026 |
| QGENQiagen N.V. | $101.55M | +4.07% | Reports Nov 4, 2026 |
| CAICaris Life Sciences, Inc. | $142.26M | +7.29% | Reports Nov 4, 2026 |
| 6869.TSysmex Corporation | $5.13B | +8.87% | Reports Nov 10, 2026 |
Turnover is the median value traded in one session, measured over the past 50 sessions. It describes trading activity in a stock and nothing about the company behind it.
Table
133 companies, largest market value first.
Data as of Oct 27, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| NTRA | Natera, Inc. | $58.36B | Large cap | +110.64% |
| DGX | Quest Diagnostics Incorporated | $26.82B | Large cap | +35.98% |
| LH | Labcorp Holdings Inc. | $26.75B | Large cap | +20.30% |
| GH | Guardant Health, Inc. | $23.25B | Large cap | +144.53% |
| TEM | Tempus AI, Inc. | $12.24B | Large cap | −26.67% |
| QGEN | Qiagen N.V. | $10.40B | Large cap | +4.07% |
| CAI | Caris Life Sciences, Inc. | $9.17B | Mid cap | +7.29% |
| 6869.T | Sysmex Corporation | $7.54B | Mid cap | +8.87% |
| ALQ.AX | ALS Limited | $7.12B | Mid cap | −8.40% |
| SHL.AX | Sonic Healthcare Limited | $6.62B | Mid cap | −9.95% |
| GRAL | GRAIL, Inc. | $6.25B | Mid cap | +64.60% |
| BLLN | BillionToOne, Inc. | $5.26B | Mid cap | +2.32% |
| ADPT | Adaptive Biotechnologies Corporation | $4.19B | Mid cap | +53.45% |
| VCYT | Veracyte, Inc. | $3.85B | Mid cap | +34.00% |
| CDNA | CareDx, Inc. | $3.57B | Mid cap | +376.22% |
| NEOG | Neogen Corporation | $2.67B | Mid cap | +96.62% |
| NEO | NeoGenomics, Inc. | $2.17B | Mid cap | +64.27% |
| PSNL | Personalis, Inc. | $1.69B | Small cap | +64.05% |
| WGS | GeneDx Holdings Corp. | $1.67B | Small cap | −53.11% |
| 4544.T | H.U. Group Holdings, Inc. | $1.31B | Small cap | −3.25% |
| OPK | OPKO Health, Inc. | $1.22B | Small cap | +12.41% |
| CSTL | Castle Biosciences, Inc. | $1.01B | Small cap | +38.98% |
| QDEL | QuidelOrtho Corporation | $944.28M | Small cap | −53.29% |
| 4694.T | BML, Inc. | $907.56M | Small cap | +2.13% |
| 137310.KS | SD Biosensor, Inc. | $583.57M | Small cap | −29.84% |
| MYGN | Myriad Genetics, Inc. | $575.81M | Small cap | −25.68% |
| FLGT | Fulgent Genetics, Inc. | $556.36M | Small cap | −13.26% |
| IDX.AX | Integral Diagnostics Limited | $548.24M | Small cap | −18.51% |
| 4549.T | Eiken Chemical Co., Ltd. | $506.10M | Small cap | +0.62% |
| VOX.WA | Voxel S.A. | $397.71M | Small cap | −7.02% |
| ACL.AX | Australian Clinical Labs Limited | $390.16M | Small cap | +11.90% |
| YDES | YD Bio Ltd | $350.62M | Small cap | −69.08% |
| 197A.T | TAUNS Laboratories,Inc. | $340.31M | Small cap | −7.74% |
| IDHC.L | Integrated Diagnostics Holdings plc | $290.66M | Small cap | −5.98% |
| OSUR | OraSure Technologies, Inc. | $287.60M | Small cap | +44.29% |
| BDSX | Biodesix, Inc. | $224.32M | Small cap | +219.70% |
| HLS.AX | Healius Limited | $224.29M | Small cap | −45.68% |
| 4595.T | Mizuho Medy Co.,Ltd. | $209.39M | Small cap | +8.62% |
| XGN | Exagen Inc. | $180.96M | Small cap | −37.28% |
| 4671.T | FALCO HOLDINGS Co., Ltd. | $171.62M | Small cap | +8.84% |
| PEB.AX | Pacific Edge Limited | $165.63M | Small cap | +11.76% |
| BNR | Burning Rock Biotech Limited | $117.59M | Small cap | −4.70% |
| IMDX | Insight Molecular Diagnostics Inc. | $98.17M | Micro cap | −53.85% |
| LUCD | Lucid Diagnostics Inc. | $95.61M | Micro cap | −60.26% |
| 6678.T | Techno Medica Co., Ltd. | $88.79M | Micro cap | +13.52% |
| QUCY | Quantum Cyber N.V. | $88.09M | Micro cap | −46.78% |
| SERA | Sera Prognostics, Inc. | $80.48M | Micro cap | −45.45% |
| BB1.AX | BlinkLab Limited | $76.74M | Micro cap | −9.49% |
| LDX.AX | Lumos Diagnostics Holdings Limited | $58.27M | Micro cap | −64.26% |
| DXR | Daxor Corporation | $53.77M | Micro cap | −19.56% |
| RENX.L | Renalytix Plc | $48.80M | Micro cap | −37.71% |
| 2385.T | Soiken Holdings Inc. | $36.03M | Micro cap | +11.86% |
| PRPO | Precipio, Inc. | $35.82M | Micro cap | −7.19% |
| RIBB | Ribbon Acquisition Corp. | $33.64M | Micro cap | −34.73% |
| CYC.AX | Cyclopharm Limited | $33.10M | Micro cap | −40.48% |
| COV.AX | Cleo Diagnostics Ltd | $30.48M | Micro cap | −25.61% |
| NN6.DE | NanoRepro AG | $24.55M | Micro cap | +4.18% |
| NXN.AX | Nexsen Limited | $22.69M | Micro cap | −28.89% |
| 6090.T | Human Metabolome Technologies, Inc. | $20.03M | Micro cap | −16.22% |
| BDX.AX | BCAL Diagnostics Limited | $19.44M | Micro cap | −4.76% |
| MDXH | MDxHealth SA | $18.58M | Micro cap | −96.01% |
| PAVM | PAVmed Inc. | $18.07M | Micro cap | −83.18% |
| MAP.AX | Microba Life Sciences Limited | $17.70M | Micro cap | −54.43% |
| 4241.T | atect corporation | $17.59M | Micro cap | +51.21% |
| RHY.AX | Rhythm Biosciences Limited | $16.15M | Micro cap | −31.58% |
| PIQ.AX | Proteomics International Laboratories Ltd | $13.93M | Micro cap | −65.22% |
| IIQ.AX | INOVIQ Ltd | $13.36M | Micro cap | −59.42% |
| GSS.AX | Genetic Signatures Limited | $12.91M | Micro cap | −77.18% |
| AT1.AX | Atomo Diagnostics Limited | $10.77M | Micro cap | −39.29% |
| BMX.WA | BioMaxima S.A. | $10.74M | Micro cap | −24.14% |
| BOUL.ST | Boule Diagnostics AB (publ) | $9.15M | Micro cap | −56.49% |
| BIOVIC-B.ST | Biovica International AB (publ) | $8.78M | Micro cap | −48.44% |
| BMRA | Biomerica, Inc. | $7.91M | Micro cap | −41.89% |
| NDRA | ENDRA Life Sciences Inc. | $7.23M | Micro cap | −9.06% |
| VRCI.L | Verici Dx plc | $6.81M | Micro cap | −71.25% |
| TRI.AX | TrivarX Limited | $6.48M | Micro cap | −68.00% |
| ACON | Aclarion, Inc. | $5.56M | Micro cap | −74.77% |
| INBS | Intelligent Bio Solutions Inc. | $5.44M | Micro cap | −83.60% |
| VNRX | VolitionRx Limited | $5.37M | Micro cap | −97.97% |
| CDIO | Cardio Diagnostics Holdings, Inc. | $5.09M | Micro cap | −56.01% |
| CNSL.L | Cambridge Nutritional Sciences plc | $4.88M | Micro cap | −33.96% |
| ADVB | Advanced Biomed Inc. | $4.51M | Micro cap | −69.67% |
| CODX | Co-Diagnostics, Inc. | $3.82M | Micro cap | −98.55% |
| BIAF | bioAffinity Technologies, Inc. | $3.63M | Micro cap | +9.27% |
| BGLC | BioNexus Gene Lab Corp. | $3.40M | Micro cap | −77.08% |
| AIDX | 20/20 Biolabs, Inc. | $2.97M | Micro cap | −99.03% |
| IBX.AX | Imagion Biosystems Limited | $2.81M | Micro cap | −82.76% |
| ADTX | Aditxt, Inc. | $2.59M | Micro cap | −100.00% |
| BJDX | Bluejay Diagnostics, Inc. | $2.50M | Micro cap | −93.86% |
| ONCO | Onconetix, Inc. | $2.09M | Micro cap | −99.78% |
| REVB | Revelation Biosciences, Inc. | $2.01M | Micro cap | −31.49% |
| VRAX | Virax Biolabs Group Limited | $1.60M | Micro cap | +103.77% |
| 2CUREX.ST | 2cureX AB | — | — | −72.73% |
| 7V0.DE | Novogenia AG | — | Small cap | −8.28% |
| AALR3.SA | Alliança Saúde e Participações S.A. | — | Small cap | −53.98% |
| AALR3F.SA | ALLIAR ON NM | — | — | −25.14% |
| ABDX.L | Abingdon Health Plc | — | — | +44.00% |
| ABLD.PA | ABL Texcell Diagnostics SA | — | — | −45.98% |
| ACARIX.ST | Acarix AB (publ) | — | Small cap | −34.17% |
| ACE.ST | Ascelia Pharma AB (publ) | — | Small cap | −81.16% |
| ALBIO.PA | Biosynex SA | — | — | +22.94% |
| ALERS.PA | Eurobio Scientific Société anonyme | — | Small cap | +2.22% |
| ALIF-B.ST | AddLife AB (publ) | — | Large cap | +2.14% |
| ALIKO.PA | Ikonisys S.A. | — | — | −5.30% |
| ALKLH.PA | Klea Holding SA | — | — | −52.49% |
| ALNOV.PA | Novacyt S.A. | — | — | −0.11% |
| ALPRE.PA | Predilife S.A. | — | — | −73.44% |
| BACTIQ.CO | BactiQuant A/S | — | Small cap | +4.93% |
| BIM.PA | bioMérieux S.A. | — | Large cap | −21.90% |
| BIOBV.HE | Biohit Oyj | — | — | −28.62% |
| BIOPOR.CO | BioPorto A/S | — | Small cap | −18.75% |
| BVXP.L | Bioventix PLC | — | Small cap | −23.81% |
| CEVI.ST | CellaVision AB (publ) | — | Mid cap | −6.97% |
| CIZ.L | Cizzle Biotechnology Holdings Plc | — | — | −29.31% |
| CLBX.L | CelLBxHealth plc | — | — | −56.76% |
| CRM.WA | PZ Cormay S.A. | — | — | +19.72% |
| DASA3.SA | Diagnósticos da América S.A. | — | Mid cap | +99.36% |
| DASA3F.SA | DASA ON NM | — | — | −2.51% |
| DIA.WA | Diagnostyka S.A. | — | Mid cap | −18.55% |
| DVYSR.ST | Devyser Diagnostics AB (publ) | — | Small cap | −62.56% |
| EKF.L | EKF Diagnostics Holdings plc | — | Small cap | −9.42% |
| ERF.PA | Eurofins Scientific SE | — | Large cap | +25.00% |
| GDR.L | genedrive plc | — | — | +115.00% |
| GENI.L | GENinCode Plc | — | — | −83.33% |
| GMT.WA | Genomtec S.A. | — | — | −56.49% |
| MBX.TO | Microbix Biosystems Inc. | — | — | +21.15% |
| N3B.F | Anbio Biotechnology | — | Small cap | −88.70% |
| NIOX.L | NIOX Group Plc | — | Small cap | −4.14% |
| OBD.L | Oxford BioDynamics Plc | — | — | −76.60% |
| S2B.WA | Syn2bio S.A. | — | Small cap | +75.29% |
| SBS.DE | Stratec SE | — | Small cap | −21.88% |
| SCP.WA | Scope Fluidics S.A. | — | Small cap | −26.97% |
| URT.WA | Urteste S.A. | — | Small cap | +24.78% |
Covers ~23,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Price and the 52-week distance are in the currency the stock trades in; only market values are converted.
We cover 133 companies grouped under the Diagnostics theme. The median market value in the group is $84.28M. Among the 55 with a price from the latest session, the median move over the past trading day is +0.38%. 33% of the 129 with a 200-day average trade above it. Price change over the past year runs from −77.2% to +49.8% across the middle 80 percent of the group, with a median of −19.6%. Across the group, 1 company currently carries a tier A volume signal.